Trials / Unknown
UnknownNCT02662881
Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE
Post-Market Data Collection for Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the performance of biologically assisted core decompression with the PerFuse instrument and BioCUE in patients with bone lesions in the femoral head. The study will explore the potential impact of patient demographics and baseline characteristics on post-operative outcomes.
Detailed description
This study will evaluate the performance of biologically assisted core decompression with the PerFuse instrument and BioCUE in patients with bone lesions in the femoral head. The study will explore the potential impact of patient demographics and baseline characteristics on post-operative outcomes. The study will evaluate change in Harris Hip Score (HHS) at 12 months after treatment. The change in AVN lesion size will also be measured at 12 months after index treatment via MRI. Change in quality of life and pain measures will be measured at each follow-up. Adverse events will also be recorded throughout the study. This study will follow patients for 5 years after initial treatment. Data will be recorded in a online database that will be entered by the site or patient, depending on the report form. This database includes data checks to compare entered data against predefined rules for range. A risk-based monitoring plan will be put in place for source data verification.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PerFuse Percutaneous Decompression System | Core decompression with PerFuse |
| DEVICE | BioCUE Platelet Concentration System | PRP injection through the PerFuse cannula into core decompression site |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2020-12-08
- Completion
- 2021-12-01
- First posted
- 2016-01-26
- Last updated
- 2021-10-20
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02662881. Inclusion in this directory is not an endorsement.